News
Sandoz announces launch of piperacillin and tazobactam for injection,...
Sandoz anounced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®, in the US. Piperacillin and tazobactam for injection is an...
News
Sanofi-aventis Establishes Research Collaboration with Harvard University
Sanofi-aventis announced a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic...
News
Bharat Biotech Announces Launched Indias First Cell-culture H1N1 Swine...
Bharat Biotech announced the launch of India?s first indigenously developed cell culture H1N1 swine fluvaccine under the brand name „HNVAC™. HNVAC™ is the only developing...
News
FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules
Dr. Reddy’s Laboratories announced that it will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bioequivalent generic version of Prevacid®* Delayed-Release Capsules,...
News
First HIV diagnostic assay Results Available in Less Than...
Ortho Clinical Diagnostics announced U.S. FDA approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2)...
News
Cephalon Announces FDA Approval of a Risk Evaluation and...
Cephalon, Inc.announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and...
News
Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc.
Bristol-Myers Squibb Company announced that it has completed its previously announced acquisition of ZymoGenetics, Inc.. As a result of the transaction, ZymoGenetics has become a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.